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Abstract
Computed tomography derived fractional flow reserve  (FFRCT) and computed tomography stress myocardial perfusion imag-
ing (CTP) are techniques to assess haemodynamic significance of coronary stenosis. To compare the diagnostic performance 
of  FFRCT and static rest/stress CTP in detecting fractional flow reserve (FFR) defined haemodynamically-significant stenosis 
(FFR ≤ 0.8). Fifty-one patients (96 vessels) with suspected coronary artery disease from a single institution planned for 
elective invasive-angiography prospectively underwent research indicated 320-detector-CT-coronary-angiography (CTA) 
and adenosine-stress CTP and invasive FFR. Analyses were performed in separate core-laboratories for  FFRCT and CTP 
blinded to FFR results. Myocardial perfusion was assessed visually and semi-quantitatively by transmural perfusion ratio 
(TPR). Invasive FFR ≤ 0.8 was present in 33% of vessels and 49% of patients.  FFRCT, visual CTP and TPR analysis was 
feasible in 96%, 92% and 92% of patients respectively. Overall per-vessel sensitivity, specificity and diagnostic accuracy for 
 FFRCT were 81%, 85%, 84%, for visual CTP were 50%, 89%, 75% and for TPR were 69%, 48%, 56% respectively. Receiver-
operating-characteristics curve analysis demonstrated larger per vessel area-under-curve (AUC) for  FFRCT (0.89) compared 
with visual CTP (0.70; p < 0.001), TPR (0.58; p < 0.001) and CTA (0.70; p = 0.0007); AUC for CTA + FFRCT (0.91) was 
higher than CTA + visual CTP (0.77, p = 0.008) and CTA + TPR (0.74, p < 0.001). Per-patient AUC for  FFRCT (0.90) was 
higher than visual CTP (0.69; p = 0.0016), TPR (0.56; p < 0.0001) and CTA (0.68; p = 0.001). Based on this selected cohort of 
patients  FFRCT is superior to visually and semi-quantitatively assessed static rest/stress CTP in detecting haemodynamically-
significant coronary stenosis as determined on invasive FFR.
Keywords Imaging · Coronary disease · Ischemia · Computed tomography · Fractional flow reserve · Myocardial perfusion 
imaging
Abbreviations
CT  Computed tomography
CTA  Computed tomography coronary angiography
FFRCT  Non-invasive CT-derived fractional flow reserve
ICA  Invasive coronary angiography
FFR  Fractional flow reserve
CFD  Computational fluid dynamics
ROC  Receiver-operating characteristics curve
AUC  Area under the curve
Introduction
Ischemia assessment remains the cornerstone management 
of stable coronary artery disease (CAD), as its presence and 
burden predicts benefit from revascularization [1, 2]. While 
CT coronary angiography (CTA) in its current form cannot 
reliably predict lesion specific ischemia, novel techniques 
such as CT stress myocardial perfusion imaging (CTP) and 
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non-invasive CT-derived fractional flow reserve have been 
demonstrated to accurately predict lesion specific ischemia 
as determined by invasive fractional flow reserve (FFR) [3, 
4]. These techniques differ widely in physiological princi-
ples, acquisition requirements, image processing and result 
interpretation.
Ischemia detection in CTP requires two scans which are 
performed during rest and vasodilator stress. When sig-
nificant ischemia is present, the lack of blood flow during 
vasodilator stress results in lower contrast attenuation in 
the distal subtended myocardium, which can be determined 
using static or dynamic acquisition. In static CTP, perfusion 
defects are typically detected visually or semi-quantitatively 
using the transmural perfusion ratio (TPR). In dynamic CTP, 
perfusion can be quantified using mathematical algorithms 
[5].
FFRCT is defined as the ratio of the CT-derived distal 
coronary and aortic pressure [6]. Pressure can be derived 
by computational fluid modeling applied on standard CT 
angiogram datasets with no need of additional medication, 
contrast or radiation. The fluid modeling is performed cen-
trally using a supercomputer in a remote location with the 
test result available within 4–24 h.
The techniques of CTP and  FFRCT are used in selected 
centres in the United States. The aim of this paper is to com-
pare the diagnostic performance of static CTP and  FFRCT 
to detect lesion specific ischemia, using the established out-
come-based reference standard of invasive FFR [7].
Methods
Symptomatic patients with no known CAD who were at 
intermediate or high risk and were scheduled for clinically 
mandated invasive coronary angiography were prospectively 
screened and enrolled from a single institution. Patients were 
excluded for age < 40 years, advanced atrioventricular block, 
atrial fibrillation, recent myocardial infarction, severe left 
main disease, renal insufficiency (estimated glomerular fil-
tration rate < 60 ml min/1.73 m2), bronchospastic lung dis-
ease requiring long term steroid therapy and contraindica-
tions to iodinated contrast or adenosine. All enrolled patients 
underwent research indicated 320-detector CTA, stress static 
CTP and invasive FFR, which was undertaken in at least 1 
major epicardial vessel with > 2 mm diameter, with a visu-
ally assessed stenosis between 10 and 90% during invasive 
angiography. The study was approved by the institutional 
human research ethics committee and all participants pro-
vided written informed consent.
CT imaging protocol
Cardiac CT assessment was performed using a 320-row 
detector CT scanner (Aquilion One Vision; Canon Medi-
cal Systems Corp, Otawara, Japan). The scan protocol 
consists of a calcium score scan, a rest CTA followed by 
a stress CTP 20 min later [8]. Patients were requested to 
refrain from caffeine 8 h prior to the scan. Prior to the rest 
CTA, patients received sublingual nitoglycerin (400 mcg) 
and beta-blockers were administered to achieve a pre-
CTA scan heart rate of 60 beats per minute. Intravenous 
adenosine (140 mcg/kg/min) was administered for 3 min 
prior to stress CTP scan acquisition. Scan parameters 
were: detector collimation 320 × 0.5 mm; tube current 
300–500 mA (depending on body mass index); tube volt-
age 120 kV if BMI ≥ 25 (100 kV if BMI < 25); temporal 
resolution of 135 ms and 75 mls of contrast were used 
in both rest CTA and stress CTP. Prospective ECG gated 
CT scans were performed at rest and during vasodilator 
stress targeting 70–99% of the R–R interval. In event of 
heart rates > 70 bpm during stress CTP, a wider window of 
acquisition between 30 and 99% was performed. CTA and 
CTP were triggered in the arterial phase at the predicted 
peak of contrast bolus for myocardial enhancement [9].
CTA analysis
The rest CTA analysis was performed in a core CTA labo-
ratory (The Heart Centre, Rigshospitalet, Denmark) by 
two interpreters (JL, MS) who were blinded to which ves-
sels were interrogated with invasive FFR, and the results 
of FFR and ICA. All coronary segments ≥ 2 mm were visu-
ally analysed and scored for degree of luminal stenosis 
on a dedicated workstation (Vitrea Fx, 6.4, Vital Images, 
USA) in accordance to the 18 segment coronary model 
[10]. A vessel was considered significantly stenotic if there 
was ≥ 1 segment which was non-evaluable or with a ≥ 50% 
luminal narrowing.
CTP analysis
Assessment of stress CTP was performed using both rest 
and stress images in a core laboratory (The Heart Centre, 
Rigshospitalet, Denmark) by two experienced interpreters 
(JL 8 years, MS 5 years) who were blinded to which ves-
sels were interrogated with invasive FFR, and the results 
of FFR and ICA with disagreement resolved by consensus.
The images were reconstructed at 3% phase intervals 
to facilitate CTP interpretation using FC03 reconstruction 
kernel [8]. The phase with the least cardiac motion was 
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selected, and images were interpreted using a narrow win-
dow width and level setting (W300/L150), and an averaged 
multiplanar reconstruction slice thickness of 3 to 5 mm.
First each of the 17 myocardial segments, according 
to the American Heart Association myocardial segment 
model [11], was matched to a major epicardial vessel, 
and visually assessed on rest and stress static CTP for the 
absence or presence of a reversible perfusion defect. A 
vessel was considered significant if a reversible perfusion 
defect was present in ≥ 1 of its matched myocardial seg-
ments. When artifacts were present in > 50% of the vessel-
subtended myocardial segments, the vessel was deemed 
uninterpretable. Reader confidence was recorded for inter-
pretation. Reader confidence of each vessel territory was 
scored on a scale of 1 to 5, 1 = very uncertain, 2 = uncer-
tain, 3 = fair, 4 = good, 5 = excellent.
For the quantitative assessment, the transmural perfu-
sion ratio was scored for each myocardial segment using 
custom analysis software (Vitrea Fx 6.4, Vital Images) 
using the same phase of images chosen for visual analysis. 
An automated border detection algorithm was applied to 
define the subendocardial and subepicardial borders after 
manual adjustments to the left ventricular axis and myo-
cardial contouring. The myocardium is divided into three 
myocardial layers—the subendocardium, mid myocardium 
and subepicardial layers, and the attenuation density in 
each layer was calculated. Transmural perfusion ratio is 
calculated as the ratio of the segment specific subendocar-
dial attenuation density to the mean attenuation density of 
the entire subepicardial layer of any given short axis slice. 
The segment with the lowest transmural perfusion ratio 
value was chosen to represent perfusion for each major 
vessel.
FFRCT analysis
The CTA dataset was sent for  FFRCT analysis at HeartFlow 
Inc., Redwood City, USA.  FFRCT analysis was completed 
using the most recent generation of  FFRCT analysis soft-
ware. First, a CT-derived luminal model of the coronary 
tree is constructed, second, physiological assumptions are 
applied to predict coronary inlet and outlet flow, pressure 
and microvascular resistance during maximal hyperemia 
[6]. Finally a numerical solution provided by a parallel 
supercomputer onto a three dimensional CT-derived mesh 
model is used to compute coronary pressures hence  FFRCT 
along the coronary tree. A luminal model of  FFRCT in 
the entire coronary tree is generated. The  FFRCT value for 
each vessel is taken as that occurring at the correspond-
ing position of the pressure wire sensor recorded during 
invasive FFR measurement. A vessel with  FFRCT ≤ 0.8 was 
considered significant.
Invasive coronary angiography and FFR
Invasive FFR was performed in the distal coronary artery as 
per standard practice after administration of intracoronary 
nitroglycerin (100mcg). It was performed in at least 1 vessel 
segment with diameter ≥ 2 mm with visual stenosis between 
10 and 90%. Decisions regarding which vessel was inter-
rogated with invasive FFR was at the discretion of the inter-
ventionist, who were blinded to the CT findings. The FFR 
value was recorded during steady state after administration 
of intravenous adenosine at 140 mcg/kg/min. Pullback of 
the pressure sensor back into the tip of the guiding catheter 
was performed, and only vessels with recording of a signal 
drift in FFR of < 0.05 were included. An FFR value of ≤ 0.8 
was chosen to define hemodynamically significant stenosis.
Endpoints
The primary endpoint was per vessel diagnostic performance 
as assessed by the area under the receiver-operating charac-
teristic curve (AUC) of  FFRCT, visually assessed CTP and 
TPR using invasive FFR ≤ 0.8 as reference standard to define 
hemodynamically significant stenosis. Secondary endpoints 
included (1) per vessel and per patient diagnostic accuracy, 
sensitivity, specificity, positive predictive value (PPV) and 
negative predictive value (NPV), (2) combined per ves-
sel CTA + visual CTP, CTA + TPR and CTA + FFRCT as 
assessed by AUC and (3) per patient diagnostic performance 
as assessed by AUC. Primary and secondary analyses was 
performed on all interpretable vessels for each technique, 
after excluding uninterpretable vessels.
Statistical analyses
Continuous variables are presented as mean ± SD if normally 
distributed whereas categorical variables are expressed 
as percentage. The Wilcoxon signed rank test was used to 
compare the median FFR values. The correlation between 
 FFRCT and invasive FFR values was determined with a 
Pearson Correlation coefficient. The AUC comparisons 
were performed on per vessel and per patient level accord-
ing to the method described by DeLong et al. [12], treating 
 FFRCT and TPR as continuous variables and visual CTP as 
dichotomous variable. Patient identity was included as a 
cluster variable to account for multiple arteries taken from 
individuals. The optimal TPR threshold (0.94) for detect-
ing FFR defined hemodynamically significant stenosis was 
determined using the Youden Index [13]. The incremental 
diagnostic value of adding  FFRCT, CTP or TPR to CTA was 
assessed by AUC using a binary logistic regression model. 
Inter-observer variability was assessed for  FFRCT, TPR, CTP 
treated as dichotomized variables using kappa statistics on 
15 randomly selected patients including 30 vessel territories. 
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Additional Bland Altman plot analysis was performed for 
 FFRCT and TPR to evaluate inter-observer reproducibility. 
Statistical analysis was performed using SPSS version 24. A 
p value < 0.05 was considered statistically significant.
Results
Patient enrollment flow chart is illustrated in Fig. 1. Among 
the 56 patients who underwent CTA, CTP and invasive FFR, 
5 patients were excluded due to truncated image [1], intera-
trial RCA (n = 1), interval revascularization (n = 1), and 
pressure wire position not recorded (n = 2). Of the remain-
ing 51 patients (including 96 FFR-interrogated vessels) 
deemed eligible for analysis, mean age was 61.9 ± 9.8 years 
and 76.5% were male. Patient and vessel characteristics and 
CT scan parameters are summarized in Tables 1, 2 and 3.
FFR ≤ 0.8 was present 25 patients (49%) including 32 
vessels (33%). Among the patients and vessels eligible 
for analysis,  FFRCT was interpretable in 49 patients (96%) 
including 91 vessels (91%).  FFRCT analysis could not be 
performed in 2 patients secondary to poor CT image quality. 
In the first case, there was excessive blooming artefact sec-
ondary to vessel calcification and in the second case, there 
was vessel motion artefact. CTP was interpretable in 47 
patients (92%) including 88 vessels (92%). The presence of 
significant motion artefacts precluded analysis in 4 patients. 
Mean reader confidence score was 4.2 ± 0.9. The number 
and percentage of vessels interpreted with reader confidence 
scores of 1, 2, 3, 4, 5 were 0 (0%), 4 (4.5%), 16 (18.2%), 26 
(29.5%), 42 (47.7%) respectively.
The distribution of  FFRCT and FFR is displayed in Sup-
plementary Figure. The box plot of visual CTP, TPR and 
 FFRCT versus invasive FFR is displayed in Fig. 2. The 
per-patient and vessel diagnostic performance of coronary 
CTA, CTP, TPR,  FFRCT is summarized in Table 4. The per 
vessel CTA + visual CTP, CTA + TPR and CTA + FFRCT 
is illustrated in Fig. 3. An example is illustrated in Fig. 4.
Fig. 1  Patient enrollment chart
Table 1  Patient characteristics
SD standard deviation
a Blood pressure > 140/90 mmHg or treatment for hypertension
b Total cholesterol > 180 mg/dl or treatment for hypercholesterolemia
N = 51 patients
Age, mean ± SD (N) 61.9 ± 9.8
Male 76.5% (39/51)
Diabetes mellitus 29.4% (15/51)
Hypertensiona 76.5% (39/51)
Hyperlipidemiab 86.2% (44/51)
Current smoker 19.6% (10/51)
Former smoker 31.4% (16/51)
Angina  typea
 Typical 19.6% (10/51)
 Atypical 56.8% (29/51)
 Non cardiac chest pain 21.6% (11/51)
Updated diamond-forrester risk score, %
 Low and Intermediate pre-test risk 80.4% (41/51)
 High pre-test risk 19.6% (10/51)
Body mass index, mean ± SD (N) 27.8 ± 4.6
Creatinine (mmol/L), mean ± SD (N) 79.6 ± 15.4
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Per vessel diagnostic performance
The primary endpoint of per-vessel AUC for  FFRCT was 
0.89, which was significantly higher than visual CTP (0.70), 
TPR (0.58) and CTA (0.70) (Fig. 3).
FFRCT had the highest per vessel sensitivity of 80.6% and 
specificity 85.0%.  FFRCT reduced the number of false posi-
tive vessels by 63% when compared with CTA. While CTP 
Table 2  Vessel characteristics Characteristics
Calcium score (median, IQR) 318 (90–1012)
Vessel
 Left anterior descending artery 44.8% (43/96)
 Left circumflex artery 18.8% (18/96)
 Right coronary artery 15.6% (15/96)
 Diagonal branch 3.1% (3/96)
 Obtuse marginal branch 12.5% (12/96)
 RPDA or RPLV branch 4.2% (5/96)
 Patients with CTCA maximum stenosis > 50% 70.6% (36/51)
 Vessels with CTCA maximum stenosis > 50% 51.0% (49/96)
Patients with  FFRCT ≤ 0.80 49.0% (24/49)
Vessels with  FFRCT ≤ 0.80 37.4% (34/91)
Patients with perfusion defect in ≥ 1 subtended myocardial segment on visual CTP 42.6% (20/47)
Vessels with perfusion defect in ≥ 1 subtended myocardial segment on visual CTP 25.0% (22/88)
Patients with perfusion defect in ≥ 1 subtended myocardial segment on TPR 63.4% (30/47)
Vessels with perfusion defect in ≥ 1 subtended myocardial segment on visual TPR 65.9% (58/88)
Patients with FFR ≤ 0.80 49.0% (25/51)
Vessels with FFR ≤ 0.80 33.0% (32/96)
Patients with FFR ≤ 0.80 in > 1 vessel 11.8% (6/51)
Table 3  Scan characteristics
CTA CTP
Nitrates 100% 0%
Beta blockers 92.1%
kV 100/120 45%/55%
Radiation exposure (mSv) 4.9 ± 2.2 5.7 ± 3.3
Contrast (ml) 75 75
Heart rate on acquisition 53.4 ± 6.2 66.5 ± 9.6
Fig. 2  Box plot correlation with FFR. a The median FFR in ves-
sels with  FFRCT ≤ 0.8 was significantly lower than in vessels with 
 FFRCT > 0.8 (p < 0.0001). b Similarly, the median FFR in vessels with 
visually assessed perfusion defect on CTP was significantly lower 
than in vessels with normal perfusion (p < 0.0001). c The median 
FFR in vessels with significant TPR was not significantly lower than 
in vessels with normal TPR (p = 0.08)
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Table 4  Per vessel and patient 
diagnostic performance
*FFRCT is superior to Visual CTP (p = 0.0001), TPR (p < 0.0001), CTA (p = 0.0007) on per vessel basis
**FFRCT is superior to Visual CTP (p = 0.0016), TPR (p < 0.0001) and CTA (p = 0.0011) on per patient 
basis
Visual CTP did not reach significance against TPR (p = 0.12) on a per-vessel basis
Visual CTP did not reach significance against TPR (p = 0.22) on a per-patient basis
CTA > 50 Visual CTP FFRCT TPR ( < 0.94)
Per vessel analysis (n = 96)
 Included vessels 96 88 91 88
 True positive 25 16 25 22
 False positive 24 6 9 29
 True negative 40 50 51 27
False negative 7 16 6 10
 Sensitivity 78.1 (60–90.7) 50.0 (31.9–68.1) 80.6 (62.5–92.5) 68.8 (50.0–83.9)
 Specificity 62.5 (49.5–74.3) 89.3 (78.1–96.0) 85.0 (73.4–92.9) 48.2 (34.7–62.0)
 PPV 51.0 (36.3–65.6) 72.7 (49.8–89.3) 73.5 (55.6–87.1) 43.1 (29.3–57.8)
 NPV 85.1 (71.7–93.8) 75.8 (63.6–85.5) 89.5 (78.5–96.0) 73.0 (55.9–86.2)
 Accuracy 67.7 75.0 83.5 55.7
 ROC AUC 0.70* (0.61–0.83) 0.70* (0.60–0.79) 0.89 (0.83–0.96) 0.58* (0.45–0.71)
Per patient analysis (n = 51)
 Included patients 51 47 49 47
 True positive 22 15 20 17
 False positive 14 5 4 13
 True negative 12 17 21 8
 False negative 3 10 4 9
 Sensitivity 88.0 (68.8–97.5) 60.0 (38.7–78.9) 83.3 (62.6–95.3) 68.0 (46.5–85.1)
 Specificity 46.2 (26.6–66.6) 77.3 (54.6–92.2) 84.0 (63.0–95.5) 40.9 (20.7–63.6)
 PPV 61.1 (43.5–76.9) 75.0 (50.9–91.3) 83.3 (62.6–95.3) 56.7 (37.4–74.5)
 NPV 80.0 (51.9–95.7) 63.0 (42.4–80.6) 84.0 (63.9–95.5) 52.9 (27.8–77.0)
 Accuracy 66.7 68.1 83.7 53.2
ROC AUC 0.68** (0.56–0.80) 0.69 (0.55–0.82) 0.90 (0.82–0.98) 0.56 (0.40–0.73)
Fig. 3  Per vessel and patient diagnostic performance. a Per ves-
sel AUC for  FFRCT was significantly higher than visual CTP 
(p < 0.0001), TPR (p < 0.0001) and CTA (p = 0.0007). b Per patient 
AUC for  FFRCT was significantly higher than CTP (p = 0.0016), TPR 
(p < 0.001) and CTA (p = 0.0011). c CTA + FFRCT had the highest 
AUC which was significantly higher than CTA alone (p = 0.0001), 
CTA + visual CTP (p = 0.0082) and CTA + TPR (p = 0.0009). The 
AUC for CTA + visual CTP was significantly higher than CTA alone 
(p = 0.02). The AUC for CTA + TPR was not significantly different 
from CTA alone (p = 0.26)
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had high per vessel specificity of 89.3%, the sensitivity was 
50.0%. TPR had low sensitivity 68.8% and specificity 48.2%.
The AUC of CTA + FFRCT was 0.91, which was signifi-
cantly higher than CTA alone (0.70), CTA + visual CTP 
(0.77) and CTA + TPR (0.74). The AUC for CTA + visual 
CTP was significantly higher than CTA alone. The AUC for 
CTA + TPR was not significantly different from CTA alone.
In vessels with CTA > 50%, the AUC for  FFRCT was 0.82, 
which was significantly higher than CTP (0.64, p = 0.025) 
and TPR (0.51, p = 0.0018). The sensitivity and specificity 
in this cohort was 79.2% and 72.7% for  FFRCT. The corre-
sponding numbers for CTP and TPR were 56.0%, 71.4% and 
60.0%, 52.4% respectively.
The median per vessel calcium score was 81. In vessels 
with a calcium score < 81, the diagnostic accuracy of  FFRCT 
was 80.0%. The corresponding values for CTP and TPR was 
80.5% and 51.2%. In vessels with a calcium score > 81, the 
diagnostic accuracy of  FFRCT was 89.4%, which was higher 
than CTP (64.1%) and TPR (48.7%).
Per patient diagnostic performance
Per patient AUC for  FFRCT was 0.90 which was significantly 
higher than CTP 0.69, TPR 0.56 and CTA 0.68. Per patient 
accuracy of  FFRCT was 83.7% with a sensitivity of 83.3%, 
specificity 84.0%. Both CTP and TPR had a lower overall 
accuracy 68.1% and 53.2%, sensitivity 60.0% and 68.0% and 
lower specificity 77.3% and 40.9% respectively.
Of the 36 patients with at least one significant CTA steno-
sis,  FFRCT was negative in 14 patients (11/14 were truly neg-
ative on FFR, 3/14 were falsely negative—mean FFR was 
0.75, range 0.68–0.80). The CTP was normal in 15 patients 
(7/15 were truly negative, 8/15 were falsely negative—mean 
FFR 0.72, range 0.53–0.80), and TPR was normal in 14 
patients (6/14 were truly negative, 8/14 were falsely nega-
tive—mean FFR 0.74, range 0.65–0.80).
Reproducibility
In 15 randomly selected patients, including 30 vessels, per 
vessel intra-observer variability of  FFRCT, visual CTP and 
TPR was modest (k = 0.49, p < 0.01, k = 0.44, p = 0.02 and 
k = 0.68, p < 0.001 respectively). Bland Altman analysis of 
 FFRCT demonstrated a non-significant mean inter-observer 
difference of 0.01 (p = 0.12) with standard deviation of 0.039 
and 95% limits of agreement of − 0.065 to 0.088. Bland–Alt-
man analysis for TPR demonstrated a mean inter-observer 
difference of − 0.017 (p = 0.18, 95% limits of agreement: 
− 0.14 to 0.10).
Discussion
This study compared the diagnostic performance of static 
CTP and  FFRCT to detect hemodynamically significant 
stenosis. Both techniques are increasingly used in clinical 
Fig. 4  Case example. A 70 year 
old man with class II angina 
was identified to have severe 
mid LAD stenosis on CTA 
and invasive angiography with 
invasive FFR of 0.65. FFR was 
not performed in the remaining 
arteries which had no significant 
stenosis. The  FFRCT in LAD 
was 0.77. Perfusion defects 
were identified visually in the 
axial images of the myocar-
dium corresponding to the mid 
anterior and septal segments. 
The TPR was significant in the 
basal and distal anterior septum 
(0.90)
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practice. In this cohort  FFRCT is superior to both visual 
CTP and TPR in diagnostic performance on both per ves-
sel and patient basis. While both visual CTP and  FFRCT 
improved the diagnostic performance of CTA when com-
bined, the improvement was higher when combined with 
 FFRCT compared with CTP. There was no improvement in 
diagnostic performance of CTA when combined with TPR. 
Performance of CTP in addition to CTA required use of 
adenosine, and additional radiation (5.7 mSv on average) 
and contrast (75 mls).
A recent metanalysis reported the per vessel sensitiv-
ity and specificity of static CTP was between 72–82% and 
83–88% respectively [14]. However the studies used have 
not devised a core-laboratory for CTP assessment. Based on 
this current core-laboratory adjudicated study, the per vessel 
sensitivity is lower than previously reported at 50%, while 
the specificity of 89% is within reported range.
A number of studies have compared the diagnostic per-
formance of static and dynamic CTP with point of care CT-
FFR using invasive FFR as reference standard [15–17]. Yang 
et al. demonstrated the AUC of point of care CT-FFR and 
static CTP acquired using second generation dual source 
CT were comparably high (0.89 for both) [16]. The sensi-
tivity of static CTP was 79%, specificity was 91%. Coenen 
et al. in a cohort of 74 patients scanned using second and 
third generation dual source CT demonstrated comparable 
AUC of dynamic stress CTP and point of care CT-FFR 
(AUC = 0.78 for both techniques) [15]. Using an indexed 
myocardial blood flow threshold, the sensitivity of CTP was 
73%, specificity was 68%. Lastly Ihdayhid et al. reported 
static visual CTP acquired using 320 detector CT had a per 
vessel sensitivity of 54%. Visual CTP had lower AUC when 
compared with onsite CT-FFR (0.89 vs. 0.72 p = 0.02) [17]. 
These results indicate that the diagnostic performance of 
CTP may potentially vary depending on the scanner used; 
and whether static or dynamic perfusion assessment is used.
The lower than predicted sensitivity for invasive 
FFR < 0.8 has been widely reported in stress perfusion 
techniques [18]. Bettencourt et al. reported per vessel and 
per patient sensitivity of 55% and 68% respectively in CTP 
[4]. According to data from meta-analysis and prospective 
multi-modality comparative trials the per vessel sensitivity 
of single photon emission computed tomography myocardial 
perfusion imaging (SPECT MPI) for FFR ≤ 0.8, was found 
to be between 36 and 57% [18–21] Similarly in the recent 
Dan-NICAD cohort, magnetic resonance perfusion imaging 
was found to have a per sensitivity of 41% [21].
This suggests inherent methodological differences in per-
fusion assessment and  FFRCT. CTP assesses for the presence 
of myocardial ischemia which may result from the presence 
of a significant epicardial stenosis, microvascular dysfunc-
tion or both—which may be better accounted by coronary 
flow reserve (CFR).  FFRCT, similar to invasive FFR, assesses 
lesion specific ischemia which results from the presence of 
a significant epicardial stenosis alone. The use of invasive 
FFR as the reference standard may hence favour the diag-
nostic performance of  FFRCT. Discrepancies between FFR 
and CFR or myocardial flow as assessed by PET have been 
described [22, 23]. Accordingly in subjects with an abnor-
mal FFR yet preserved CFR, stress CTP may be normal, 
despite the presence of a FFR significant stenosis.
There are a number of strengths in this study. First core 
lab analysis for both CTP and  FFRCT was performed blinded 
to invasive FFR. Notably in similar comparison studies, 
core lab adjudicated CTP assessment has not been used. 
Second the study is investigator initiated without support 
from industry or CT vendor, hence reducing potential bias. 
Third, static CTP has been assessed using both visual and 
semi-quantitative methods. Lastly the  FFRCT location was 
matched exactly with the pressure sensor location at time 
of invasive FFR measurement. The values for  FFRCT and 
invasive FFR changes along the length of coronary artery 
[24], and meticulous matching assists in discerning true 
correlation.
There are limitations in this study. (1) This study included 
limited number of patients enrolled from a single institution. 
(2) The study cohort included patients referred for clinically 
mandated elective ICA, and the invasive FFR and CTA/
CTP had been performed for research purpose alone. Nota-
bly invasive FFR was not performed in all vessels, but at 
discretion of the interventionist. For this reason, the results 
may not be generalised to lower risk cohorts with suspected 
CAD referred for clinically mandated coronary CTA. (3) Our 
results compared static CTP acquired using 320 detector sin-
gle source CT with  FFRCT. These results cannot be conferred 
to other CTP techniques including dynamic perfusion, dual 
energy CTP, or CTP performed using other scanner technol-
ogy including dual source CT. (4) The study only included 
patients with suspected disease and excluded patients with 
stenting. Diagnostic performance in these patients, in whom 
CTP may confer a potential advantage is unknown [25]. (5) 
Beta blockers and sublingual GTN were administered prior 
to rest CTA, as had been previously described. These may 
influence the accuracy of the stress CTP.
Conclusion
Based on the results of this core lab adjudicated single insti-
tution cohort with 320-detector CTA, CTP and invasive 
FFR,  FFRCT demonstrated superior diagnostic performance 
when compared with visual and semi-quantitatively assessed 
static CTP for detection of hemodynamically significant ste-
nosis as assessed on invasive FFR on both per vessel and 
patient basis. While both visual CTP and  FFRCT improved 
the diagnostic performance of CTA when combined, the 
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improvement was higher when combined with  FFRCT com-
pared with visual CTP. Semiquantitative TPR perfusion 
assessment did not improve the diagnostic performance of 
CTA. Future prospective multicenter core laboratory adju-
dicated trials may assist in validating these results.
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